Product Overview
Buy Cabergoline by Zyvex Pharmaceuticals at Best Anabolic Steroids. The unit is a single carton of one hundred white tablets, 2 mg apiece, and the active substance is an ergot-derived agonist at the dopamine D2 receptor. Agonists of this receptor tell the pituitary to release less prolactin, which is the whole point of the product and also the reason it is a prescription medicine rather than a support tablet in the ordinary sense.
Two strengths exist in pharmacy and they are not interchangeable. Cabaser, used in Parkinson disease, is the 2 mg product. Dostinex, used for raised prolactin, is 0.5 mg, and the approved ceiling for that indication is 1 mg twice a week. The Zyvex box carries the higher strength, so anyone working from a label schedule has to divide a tablet into halves or quarters, and a split that lands anywhere will move the true dose by a large fraction. A pill cutter and a fixed routine matter more here than on almost any other product in the catalogue.
Raised prolactin is not a cosmetic problem. It suppresses gonadotropin release, so libido, morning erections, mood and semen quality fall away while the number climbs, and it can produce tenderness or a small amount of fluid from the nipple. Nineteen-nor compounds are the usual suspect in a bodybuilding context, which is why this page sits beside the Nandrolone Esters and Trenbolone Esters cards rather than beside the mass builders.
Dosage Protocol
The rows below are the approved titration from the prescription label, quoted so that the figures in the literature make sense. They are not a schedule for a self-directed course, and no confirmed non-medical protocol exists.
| Level | Amount | Length | Note |
| Starting step | 0.25 mg twice weekly | Titration | Label starting dose, raised in 0.25 mg steps with at least four weeks between them |
| Middle step | 0.5 mg twice weekly | By indication | The ordinary pharmacy strength, reached only if the first step does not hold the number |
| Upper step | 1 mg twice weekly | By indication | The maximum the label allows, and the point where monitoring stops being optional |
| Female | Not confirmed | - | No safe non-medical protocol appears in the sources |
| Route | Oral tablet | Scheduled | The long half-life supports one or two doses a week, which is why accurate splitting matters |
Pharmacokinetics explain the rhythm. Healthy volunteers clear the molecule with a half-life of 63 to 69 hours, and modelling in patients with raised prolactin returns figures from 79 to 115 hours. Nothing in the day-to-day level swings much once a dose is established, so there is no benefit in taking it more often, and a doubling of frequency simply doubles the exposure.
Suggested Protocols
Prolactin control is a single, narrow job. The arrangements below come from user practice and from the literature on nineteen-nor cycles; none of them is an approved indication.
What to Expect
- Prolactin falls over weeks, not days. Long-term therapy normalises the figure in a share of patients, and the curve is slow in both directions.
- Libido and morning erections are usually the first things to return when the number was genuinely high, because the pituitary brake on gonadotropins loosens.
- Nothing about training changes. This molecule builds no tissue, adds no strength and has no anabolic action of any kind.
- Nipple tenderness and discharge improve if prolactin was the driver; if estrogen is the driver, the answer sits elsewhere on the page.
- Tolerability is front-loaded. Nausea, headache and dizziness cluster in the first days and after each step up, then settle.
- A number that stays high on treatment is a referral question, not a reason to raise the dose. Pituitary imaging is the medical next step.
Side Effects and Management
Cumulative exposure is the variable that matters for the valve risk, with a figure near 300 mg of total dose quoted in prolactinoma data as a safety landmark. Split evenly, the 2 mg box here represents about a year of 0.5 mg twice-weekly dosing, so the arithmetic of a long plan is worth doing before the first tablet rather than later.
Post-Cycle Therapy and Axis Recovery
This product is not a recovery drug. Cabergoline does not raise luteinising hormone the way a SERM does, so it cannot replace Clomid Clomiphene or Nolvadex Tamoxifen after a suppressive course. Where it is discussed in the recovery context, the mechanism is indirect: if prolactin was the brake on the axis, removing that brake lets the natural signal recover on its own.